chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Gait disturbance
Clinical narrative: Covid-19 positive  after first dose of vaccine (fever,chills,coughing,joint pain,diarrhea,sluggishness,loss of appetite,weightloss); Could barely walk; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 positive  after first dose of vaccine (fever,chills,coughing,joint pain,diarrhea,sluggishness,loss of appetite,weightloss)) and GAIT DISTURBANCE (Could barely walk) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O11L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced GAIT DISTURBANCE (Could barely walk). On an unknown date, the patient experienced COVID-19 (Covid-19 positive  after first dose of vaccine (fever,chills,coughing,joint pain,diarrhea,sluggishness,loss of appetite,weightloss)). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid-19 positive  after first dose of vaccine (fever,chills,coughing,joint pain,diarrhea,sluggishness,loss of appetite,weightloss)) and GAIT DISTURBANCE (Could barely walk) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment medications included ibuprofen and acetaminophen to relieve side effects.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pain, Vomiting
Clinical narrative: Pain; Nausea; Vomitting; Body Aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), NAUSEA (Nausea), VOMITING (Vomitting), MYALGIA (Body Aches) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN (Pain), NAUSEA (Nausea), VOMITING (Vomitting), MYALGIA (Body Aches) and HEADACHE (Headache). The patient was treated with IBUPROFEN at a dose of 1 dosage form and OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) at a dose of 1 dosage form. At the time of the report, PAIN (Pain), NAUSEA (Nausea), VOMITING (Vomitting), MYALGIA (Body Aches) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2021: Follow up received on 24-JAN-2021. No new information was reported. On 18-Feb-2021: NO new information
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: blood sugar numbers spiked about 80 points- went to 120 to over 200; This spontaneous case was reported by a consumer and describes the occurrence of   in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011120A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy ("Loratad"), Fibroids, Diabetes, Blood pressure high and Stenosis.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with METFORMIN ongoing since an unknown date for Blood sugar increased, at a dose of UNK, bid.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Blood glucose: 120 to over 200 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included "several prescribed medications" to treat the conditions of fibroids, diabetes, high blood pressure and stenosis.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Dizziness, Dysphonia, Gait disturbance
Clinical narrative: his voice has changed over the last several days; dizzy; He has been unable to walk normally but only shuffle; feeling sick; nauseous; vomited; chills; he did not eat with the exception of soda and ice pops until Sunday 17-Jan-2021; He had 3 nights of sweating during sleep; He has lost 7 lbs in the past week; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling sick), NAUSEA (nauseous), VOMITING (vomited), CHILLS (chills) and DECREASED APPETITE (he did not eat with the exception of soda and ice pops until Sunday 17-Jan-2021) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced WEIGHT DECREASED (He has lost 7 lbs in the past week). On 13-Jan-2021, the patient experienced MALAISE (feeling sick), NAUSEA (nauseous), VOMITING (vomited), CHILLS (chills), DECREASED APPETITE (he did not eat with the exception of soda and ice pops until Sunday 17-Jan-2021), NIGHT SWEATS (He had 3 nights of sweating during sleep) and GAIT DISTURBANCE (He has been unable to walk normally but only shuffle). On 19-Jan-2021, the patient experienced DIZZINESS (dizzy). On an unknown date, the patient experienced DYSPHONIA (his voice has changed over the last several days). The patient was treated with AZITHROMYCIN (Z-PAK) at an unspecified dose and frequency. On 16-Jan-2021, NIGHT SWEATS (He had 3 nights of sweating during sleep) had resolved. On 17-Jan-2021, NAUSEA (nauseous) and VOMITING (vomited) had resolved. On 19-Jan-2021, WEIGHT DECREASED (He has lost 7 lbs in the past week) had resolved. At the time of the report, MALAISE (feeling sick), CHILLS (chills), DECREASED APPETITE (he did not eat with the exception of soda and ice pops until Sunday 17-Jan-2021), DYSPHONIA (his voice has changed over the last several days), DIZZINESS (dizzy) and GAIT DISTURBANCE (He has been unable to walk normally but only shuffle) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea, Night sweats, Vomiting, Weight decreased
Clinical narrative: his voice has changed over the last several days; dizzy; He has been unable to walk normally but only shuffle; feeling sick; nauseous; vomited; chills; he did not eat with the exception of soda and ice pops until Sunday 17-Jan-2021; He had 3 nights of sweating during sleep; He has lost 7 lbs in the past week; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling sick), NAUSEA (nauseous), VOMITING (vomited), CHILLS (chills) and DECREASED APPETITE (he did not eat with the exception of soda and ice pops until Sunday 17-Jan-2021) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced WEIGHT DECREASED (He has lost 7 lbs in the past week). On 13-Jan-2021, the patient experienced MALAISE (feeling sick), NAUSEA (nauseous), VOMITING (vomited), CHILLS (chills), DECREASED APPETITE (he did not eat with the exception of soda and ice pops until Sunday 17-Jan-2021), NIGHT SWEATS (He had 3 nights of sweating during sleep) and GAIT DISTURBANCE (He has been unable to walk normally but only shuffle). On 19-Jan-2021, the patient experienced DIZZINESS (dizzy). On an unknown date, the patient experienced DYSPHONIA (his voice has changed over the last several days). The patient was treated with AZITHROMYCIN (Z-PAK) at an unspecified dose and frequency. On 16-Jan-2021, NIGHT SWEATS (He had 3 nights of sweating during sleep) had resolved. On 17-Jan-2021, NAUSEA (nauseous) and VOMITING (vomited) had resolved. On 19-Jan-2021, WEIGHT DECREASED (He has lost 7 lbs in the past week) had resolved. At the time of the report, MALAISE (feeling sick), CHILLS (chills), DECREASED APPETITE (he did not eat with the exception of soda and ice pops until Sunday 17-Jan-2021), DYSPHONIA (his voice has changed over the last several days), DIZZINESS (dizzy) and GAIT DISTURBANCE (He has been unable to walk normally but only shuffle) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: pain in the same arm of injection; Tenderness; Vaccination site pruritus; real red  at the injection site; Vaccination site swelling; warm to the touch  at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of   in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with CORTISONE at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment medication included antihistamines for 24 hour.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: arm swelling around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (arm swelling around the injection site) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE SWELLING (arm swelling around the injection site). At the time of the report, VACCINATION SITE SWELLING (arm swelling around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Headache, Pain, Pain in extremity
Clinical narrative: my arm  got extremely sore; my arm was really hot, it hurt; bad headache; sore all over; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (my arm  got extremely sore), DISCOMFORT (my arm was really hot, it hurt), HEADACHE (bad headache) and PAIN (sore all over) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol (Use of Cholesterol medicine), Salicylate (Usage of Baby aspirin noted), Glaucoma (Takes glaucoma medication) and Dry eye (Takes dry eye medication). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (my arm  got extremely sore), DISCOMFORT (my arm was really hot, it hurt), HEADACHE (bad headache) and PAIN (sore all over). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 14-Jan-2021, PAIN IN EXTREMITY (my arm  got extremely sore), DISCOMFORT (my arm was really hot, it hurt), HEADACHE (bad headache) and PAIN (sore all over) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included cholesterol medicine, medication for glaucoma and dry eye medication.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: This is a spontaneous report received from a consumer, concerning a 55-year-old, female patient, who received the Moderna COVID-19 vaccine (mRNA-1273) and experienced hives in front of her chest with red and raised bumps. The patient's medical history and concomitant medications not provided. On Jan 16, 2021 (prior to the onset of the events), patient received their first of two planned doses of mRNA-1273 (Lot number: 039K202A) for prophylaxis of COVID-19 infection. Prior to receiving mRNA-1273, on Jan 18, 2021, patient felt hives in front of her chest with red and raised bumps. Treatment for the events included Benadryl. Action taken with mRNA-1273 in response to the events not reported. The outcome of the hives in front of chest with red and raised bumps: not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Injection site discomfort, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: soreness at injection site; redness at the injection site; Hotness at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOMFORT (soreness at injection site), INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE WARMTH (Hotness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced INJECTION SITE DISCOMFORT (soreness at injection site), INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE WARMTH (Hotness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site). At the time of the report, INJECTION SITE DISCOMFORT (soreness at injection site), INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE WARMTH (Hotness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: localized swelling; hurts when she presses on it; her arm feels heavy and can't lift it that much; Injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Injection site was red), INJECTION SITE SWELLING (localized swelling), INJECTION SITE PAIN (hurts when she presses on it) and INJECTED LIMB MOBILITY DECREASED (her arm feels heavy and can't lift it that much) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE ERYTHEMA (Injection site was red). On an unknown date, the patient experienced INJECTION SITE SWELLING (localized swelling), INJECTION SITE PAIN (hurts when she presses on it) and INJECTED LIMB MOBILITY DECREASED (her arm feels heavy and can't lift it that much). At the time of the report, INJECTION SITE ERYTHEMA (Injection site was red), INJECTION SITE SWELLING (localized swelling), INJECTION SITE PAIN (hurts when she presses on it) and INJECTED LIMB MOBILITY DECREASED (her arm feels heavy and can't lift it that much) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event following immunisation
Clinical narrative: i've got a consumer with a potential adverse event.; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNISATION (i've got a consumer with a potential adverse event.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (i've got a consumer with a potential adverse event.). At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (i've got a consumer with a potential adverse event.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided. As per client,  error in DOB
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Vaccination complication
Clinical narrative: chills; body aches; Not feeling well; fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), MYALGIA (body aches) and VACCINATION COMPLICATION (Not feeling well) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced PYREXIA (fever) and VACCINATION COMPLICATION (Not feeling well). On an unknown date, the patient experienced CHILLS (chills) and MYALGIA (body aches). At the time of the report, PYREXIA (fever), CHILLS (chills), MYALGIA (body aches) and VACCINATION COMPLICATION (Not feeling well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.  No concomitant medication was provided.    Most recent FOLLOW-UP information incorporated above includes: On 20-Jan-2021: adverse event updated
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Headache
Clinical narrative: headache; COVID 19; loss of smell; loss of taste; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), COVID-19 (COVID 19), ANOSMIA (loss of smell) and AGEUSIA (loss of taste) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037KD0A) for COVID-19 vaccination.     Concomitant products included VITAMIN C [ASCORBIC ACID], ACETYLSALICYLIC ACID (ASPRIN) and COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced HEADACHE (headache), COVID-19 (COVID 19), ANOSMIA (loss of smell) and AGEUSIA (loss of taste). On 10-Jan-2021, HEADACHE (headache) had resolved. In January 2021, COVID-19 (COVID 19) had resolved. On 20-Jan-2021, ANOSMIA (loss of smell) and AGEUSIA (loss of taste) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Warm around the injection site; itchiness around the injection site; pink around the injection site; swelling around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warm around the injection site), INJECTION SITE PRURITUS (itchiness around the injection site), INJECTION SITE ERYTHEMA (pink around the injection site) and INJECTION SITE SWELLING (swelling around the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013620A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced INJECTION SITE WARMTH (Warm around the injection site), INJECTION SITE PRURITUS (itchiness around the injection site), INJECTION SITE ERYTHEMA (pink around the injection site) and INJECTION SITE SWELLING (swelling around the injection site). At the time of the report, INJECTION SITE WARMTH (Warm around the injection site), INJECTION SITE PRURITUS (itchiness around the injection site), INJECTION SITE ERYTHEMA (pink around the injection site) and INJECTION SITE SWELLING (swelling around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: U
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Urticaria around the site; Redness around the site; swelling around the site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of INJECTION SITE ERYTHEMA (Redness around the site) and INJECTION SITE SWELLING (swelling around the site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (Redness around the site) and INJECTION SITE SWELLING (swelling around the site). At the time of the report, INJECTION SITE ERYTHEMA (Redness around the site) and INJECTION SITE SWELLING (swelling around the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.    This case was linked to MOD-2021-005587 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effect; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash around the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE RASH (rash around the injection site). At the time of the report, VACCINATION SITE RASH (rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details not reported by the reporter.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain assessment, Vaccination site erythema, Vaccination site induration, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: hardness at injection site; Large red spot 3 and a half inches; injection site tender; Can't raise hand; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Can't raise hand), VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE ERYTHEMA (Large red spot 3 and a half inches) and VACCINATION SITE PAIN (injection site tender) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history).    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Can't raise hand). On 15-Jan-2021, the patient experienced VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE ERYTHEMA (Large red spot 3 and a half inches) and VACCINATION SITE PAIN (injection site tender). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Can't raise hand), VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE ERYTHEMA (Large red spot 3 and a half inches) and VACCINATION SITE PAIN (injection site tender) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Pain assessment (0-10): 6.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment included Benadryl.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Brown spot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Brown spot) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Leukemia.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Brown spot). At the time of the report, VACCINATION SITE RASH (Brown spot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details were not reported by the reporter.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Cough, Fatigue, Nausea, Pyrexia
Clinical narrative: coughing; low fever 99 up to 100.3 ° F; single episode of nausea and vomiting; single episode of nausea and vomiting; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing), PYREXIA (low fever 99 up to 100.3 ° F), NAUSEA (single episode of nausea and vomiting), VOMITING (single episode of nausea and vomiting) and FATIGUE (fatigue) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced COUGH (coughing), PYREXIA (low fever 99 up to 100.3 ° F), NAUSEA (single episode of nausea and vomiting), VOMITING (single episode of nausea and vomiting) and FATIGUE (fatigue). On 15-Jan-2021, NAUSEA (single episode of nausea and vomiting), VOMITING (single episode of nausea and vomiting) and FATIGUE (fatigue) had resolved. On 17-Jan-2021, PYREXIA (low fever 99 up to 100.3 ° F) had resolved. At the time of the report, COUGH (coughing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: low 99 upto 100.3 (Inconclusive) Low 99 upto 100.3. On 15-Jan-2021, SARS-CoV-2 test:. On 18-Jan-2021, SARS-CoV-2 test: (Positive) Test was conducted on 16-Jan-2021.  Result was positive on 18-Jan-2021..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included epilepsy medication. Treatment included ibuprofen.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vomiting
Clinical narrative: coughing; low fever 99 up to 100.3 ° F; single episode of nausea and vomiting; single episode of nausea and vomiting; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing), PYREXIA (low fever 99 up to 100.3 ° F), NAUSEA (single episode of nausea and vomiting), VOMITING (single episode of nausea and vomiting) and FATIGUE (fatigue) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced COUGH (coughing), PYREXIA (low fever 99 up to 100.3 ° F), NAUSEA (single episode of nausea and vomiting), VOMITING (single episode of nausea and vomiting) and FATIGUE (fatigue). On 15-Jan-2021, NAUSEA (single episode of nausea and vomiting), VOMITING (single episode of nausea and vomiting) and FATIGUE (fatigue) had resolved. On 17-Jan-2021, PYREXIA (low fever 99 up to 100.3 ° F) had resolved. At the time of the report, COUGH (coughing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: low 99 upto 100.3 (Inconclusive) Low 99 upto 100.3. On 15-Jan-2021, SARS-CoV-2 test:. On 18-Jan-2021, SARS-CoV-2 test: (Positive) Test was conducted on 16-Jan-2021.  Result was positive on 18-Jan-2021..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included epilepsy medication. Treatment included ibuprofen.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Insomnia, Vaccination site erythema, Vaccination site pain
Clinical narrative: difficulty sleeping; hip pain, knee pain, ankle pain, back pain; injection site is red, and irregular, at about the size of a quarter; A few chills at night; pain slightly below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (difficulty sleeping), ARTHRALGIA (hip pain, knee pain, ankle pain, back pain), VACCINATION SITE PAIN (pain slightly below the injection site), VACCINATION SITE ERYTHEMA (injection site is red, and irregular, at about the size of a quarter) and CHILLS (A few chills at night) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Arthritis, Hip bursitis and Joint pain (join pain in her back, knees, hips, and ankles).    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain slightly below the injection site). On an unknown date, the patient experienced INSOMNIA (difficulty sleeping), ARTHRALGIA (hip pain, knee pain, ankle pain, back pain), VACCINATION SITE ERYTHEMA (injection site is red, and irregular, at about the size of a quarter) and CHILLS (A few chills at night). At the time of the report, INSOMNIA (difficulty sleeping), ARTHRALGIA (hip pain, knee pain, ankle pain, back pain), VACCINATION SITE PAIN (pain slightly below the injection site), VACCINATION SITE ERYTHEMA (injection site is red, and irregular, at about the size of a quarter) and CHILLS (A few chills at night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication details were not reported by the reporter. Treatment included Meloxicam, Voltaren, 4% lidocaine patches.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Lymphadenopathy
Clinical narrative: lump under left arm of the size a golf ball; lymph node is swollen; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (lump under left arm of the size a golf ball) and LYMPHADENOPATHY (lymph node is swollen) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY MASS (lump under left arm of the size a golf ball) and LYMPHADENOPATHY (lymph node is swollen). At the time of the report, AXILLARY MASS (lump under left arm of the size a golf ball) and LYMPHADENOPATHY (lymph node is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site infection, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Infection on injection site; Large dark red on the injection site; Injection site was swollen; Injection site was warm; injection site was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site was warm), VACCINATION SITE INFECTION (Infection on injection site), VACCINATION SITE ERYTHEMA (Large dark red on the injection site), VACCINATION SITE SWELLING (Injection site was swollen) and VACCINATION SITE PAIN (injection site was sore) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.     On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site was sore). On 16-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Injection site was warm). On 17-Jan-2021, the patient experienced VACCINATION SITE INFECTION (Infection on injection site), VACCINATION SITE ERYTHEMA (Large dark red on the injection site) and VACCINATION SITE SWELLING (Injection site was swollen). On 11-Jan-2021, VACCINATION SITE PAIN (injection site was sore) had resolved. At the time of the report, VACCINATION SITE WARMTH (Injection site was warm), VACCINATION SITE INFECTION (Infection on injection site), VACCINATION SITE ERYTHEMA (Large dark red on the injection site) and VACCINATION SITE SWELLING (Injection site was swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment included advil and amoxicillin.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Rash, Vaccination site pain
Clinical narrative: Shoulder tenderness; Got a rash on the chest; Nausea; Chills; Headache; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Shoulder tenderness), RASH (Got a rash on the chest), NAUSEA (Nausea), CHILLS (Chills) and HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Shoulder tenderness), RASH (Got a rash on the chest), NAUSEA (Nausea), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, VACCINATION SITE PAIN (Shoulder tenderness), RASH (Got a rash on the chest), NAUSEA (Nausea), CHILLS (Chills) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment included ibuprofen.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hordeolum, Vaccination site erythema, Vaccination site pain, Vaccination site rash
Clinical narrative: rash; swelling of 4 inches; left arm where she got the injection site turned red; left arm where she got the injection turned sore; sharp pain in the knee; got a sty on her upper eye lid; This spontaneous case was reported by a consumer and describes the occurrence of HORDEOLUM (got a sty on her upper eye lid), VACCINATION SITE ERYTHEMA (left arm where she got the injection site turned red), VACCINATION SITE PAIN (left arm where she got the injection turned sore), VACCINATION SITE RASH (rash) and VACCINATION SITE SWELLING (swelling of 4 inches) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.     On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced HORDEOLUM (got a sty on her upper eye lid) and ARTHRALGIA (sharp pain in the knee). On 18-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (left arm where she got the injection site turned red) and VACCINATION SITE PAIN (left arm where she got the injection turned sore). On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (rash) and VACCINATION SITE SWELLING (swelling of 4 inches). At the time of the report, HORDEOLUM (got a sty on her upper eye lid) and ARTHRALGIA (sharp pain in the knee) had resolved and VACCINATION SITE ERYTHEMA (left arm where she got the injection site turned red), VACCINATION SITE PAIN (left arm where she got the injection turned sore), VACCINATION SITE RASH (rash) and VACCINATION SITE SWELLING (swelling of 4 inches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included something for thyroid and cholesterol. Treatment details not reported by reporter.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: rash; swelling of 4 inches; left arm where she got the injection site turned red; left arm where she got the injection turned sore; sharp pain in the knee; got a sty on her upper eye lid; This spontaneous case was reported by a consumer and describes the occurrence of HORDEOLUM (got a sty on her upper eye lid), VACCINATION SITE ERYTHEMA (left arm where she got the injection site turned red), VACCINATION SITE PAIN (left arm where she got the injection turned sore), VACCINATION SITE RASH (rash) and VACCINATION SITE SWELLING (swelling of 4 inches) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.     On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced HORDEOLUM (got a sty on her upper eye lid) and ARTHRALGIA (sharp pain in the knee). On 18-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (left arm where she got the injection site turned red) and VACCINATION SITE PAIN (left arm where she got the injection turned sore). On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (rash) and VACCINATION SITE SWELLING (swelling of 4 inches). At the time of the report, HORDEOLUM (got a sty on her upper eye lid) and ARTHRALGIA (sharp pain in the knee) had resolved and VACCINATION SITE ERYTHEMA (left arm where she got the injection site turned red), VACCINATION SITE PAIN (left arm where she got the injection turned sore), VACCINATION SITE RASH (rash) and VACCINATION SITE SWELLING (swelling of 4 inches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included something for thyroid and cholesterol. Treatment details not reported by reporter.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pruritus
Clinical narrative: Sore Throat; Itchy Sensation; This spontaneous case was reported by a patient and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat) and PRURITUS (Itchy Sensation) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat) and PRURITUS (Itchy Sensation). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat) and PRURITUS (Itchy Sensation) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment medication was not reported by the reporter.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Headache, Myalgia, Nausea, Vaccination site erythema
Clinical narrative: Injection site itchy; Swelling on the injection site; Asthma; Injection site hardness; Injection site red; Body ache; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma), VACCINATION SITE INDURATION (Injection site hardness), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Swelling on the injection site) and VACCINATION SITE ERYTHEMA (Injection site red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Injection site hardness), VACCINATION SITE ERYTHEMA (Injection site red), MYALGIA (Body ache), HEADACHE (Headache) and NAUSEA (Nausea). On 15-Jan-2021, the patient experienced ASTHMA (Asthma), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE SWELLING (Swelling on the injection site). On 08-Jan-2021, MYALGIA (Body ache), HEADACHE (Headache) and NAUSEA (Nausea) had resolved. At the time of the report, ASTHMA (Asthma) was resolving and VACCINATION SITE INDURATION (Injection site hardness), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Swelling on the injection site) and VACCINATION SITE ERYTHEMA (Injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment included Benadryl inhaler.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site itchy; Swelling on the injection site; Asthma; Injection site hardness; Injection site red; Body ache; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma), VACCINATION SITE INDURATION (Injection site hardness), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Swelling on the injection site) and VACCINATION SITE ERYTHEMA (Injection site red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Injection site hardness), VACCINATION SITE ERYTHEMA (Injection site red), MYALGIA (Body ache), HEADACHE (Headache) and NAUSEA (Nausea). On 15-Jan-2021, the patient experienced ASTHMA (Asthma), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE SWELLING (Swelling on the injection site). On 08-Jan-2021, MYALGIA (Body ache), HEADACHE (Headache) and NAUSEA (Nausea) had resolved. At the time of the report, ASTHMA (Asthma) was resolving and VACCINATION SITE INDURATION (Injection site hardness), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Swelling on the injection site) and VACCINATION SITE ERYTHEMA (Injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment included Benadryl inhaler.